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Differentiation of Cultured Epithelial Cells:
Response to Toxic Agents
by Robert H. Rice,* Anthony D. LaMontagne,*
Catherine T. Petito,* and Xianhui Rong*
Cell culture systems are instrumental in elucidating regulation of normal function and mechanisms of its
perturbation by toxic substances. To this end, three applications of epithelial cells cultured with 3T3 feeder
layer support are described. First, treatment of the premalignant human epidermal keratinocyte line SCC-12F2
with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate suppressed cell growth and differentiation.
This agent produced a biphasic growth response greatly inhibiting cell growth at 1 to 10 nM, but much less
above 100 nM. Expression of the differentiated functions involucrin and transglutaminase was found to be
inhibited markedly at concentrations above 10 nM. Second, 3-methylcholanthrene toxicity was surveyed in
a variety of rat epithelial cell types. The two most sensitive to growth inhibition were epidermal and mam-
mary epithelial cells, while those from bladder, prostate, thyroid, and endometrium were insensitive to growth
inhibition. Great differences were evident even among those cells derived from stratified squamous epithe-
lia (epidermal, esophageal, vaginal, forestomach) despite their expression of aryl hydrocarbon hydroxylase
activities to similar degrees. Finally, expression of estrogen receptors in rat endometrial cells was shown to
be stimulated by the cAMP-elevating agent forskolin. Maximal stimulation of 3- to 6-fold occurred in 6 hr,
compatible with a requirement for protein synthesis. Although expressing keratinocyte character (trans-
glutaminase activity and envelope forming ability), the cells thus retain some hormonal character that may
be modulated by cAMP-dependent kinase activity. Pursuit of such results will aid in understanding differ-
ences in response among cell types and species, in elucidating mechanisms of action of known toxic substances
and, ultimately, in predicting toxicity of less well understood agents.
Introduction
Despite the variety of toxicity testing methods now
available, vexing uncertainties persist in estimating the
risk to humans posed by environmental contaminants.
Major problems arise in extrapolating test results among
species, from high to low doses, and to chemical mixtures.
Advances in dealing with these uncertainties are antici-
pated to result from better mechanistic understanding of
the interactions of agents with target cells. In turn, as
differentiated functions of target cells become better un-
derstood, the actions of toxic agents will be more readily
elucidated. An added incentive to examining the pertur-
bation of cellular processes is that such study is likely to
provide further insight into normal regulatory and de-
velopmental phenomena, some of which are poorly under-
stood at present.
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Inasmuch as they are common targets of environmen-
tal agents, keratinocytes are especially appropriate for
this type of investigation. Considerable information has
accumulated on the differentiated functions of this cell
type (1), which can now be serially cultivated from hu-
mans and various animal species. Among the useful mar-
kers of keratinocyte maturation available for study (in-
cluding filaggrin and the keratin intermediate filament
proteins) are involucrin and keratinocyte trans-
glutaminase. The latter is a membrane-bound enzyme
responsible for cross-linking involucrin (2,3) and certain
other proteins (4,5) into insoluble cornified envelope struc-
tures (6,7). Involucrin is found throughout the primate
order (8) but has been difficult to identify in other aniimals,
although evidence has been reported recently for a
related protein in bovine epidermis (9). Keratinocyte
transglutaminase is distinct from the tissue trans-
glutaminase found in many cell types in its regulation and
its biochemical and immunochemical properties (7,10,11).
The relationships of these enzymes to the soluble trans-
glutaminases purified from epidermis and hair follicle are
uncertain (12-14).
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One approach to investigating toxic mechanisms in cul-
ture has been to examine directly the neoplastic response
of keratinocytes to tumor initiators, promoters, and on-
cogenes (15), in some cases treating the animal skin be-
fore cultivation (16). This work often exploits the sensi-
tivity of normal but not transformed murine cells to high
calcium medium, where they terrninally differentiate (17).
Both normal and malignant human keratinocytes express
xenobiotic metabolism (e.g., aryl hydrocarbon hydroxy-
lase) in culture and consequently are sensitive to DNA
damage and the mutagenic action of polycyclic aromatic
hydrocarbons and related agents. Applicability of these
cells to investigating mechanisms of mutagenesis and to
screening of unknowns for mutagenic potency has been
described (18).
A second approach to studying toxic mechanisms has
been to examine the physiological modulation of keratino-
cyte differentiation and its disturbance by model agents.
Acquisition of malignancy is generally a multistep process
that can be set in motion by genetic damage, although al-
teration of developmental or other processes not clearly
involving DNA damage can be important (19). Rare
genetic events often appear to be rate limiting, but recent
evidence points to a role for common cellular events in
carcinogen-treated populations in enhancing the incidence
or detection of malignant change (20,21). Moreover, the
desirability of testing for chronic toxicity other than car-
cinogenesis is evident. Interference of model agents in the
regulation of cellular processes or responses to signals
from their microenvironment may be diagnostic for a va-
riety of syndromes, possibly even at target sites other
than stratified squamous epithelia.
For example, in view of their responsiveness to
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (22), as well as
to a number of endogenous effectors of differentiation,
keratinocytes (including cell lines derived from neoplasias)
provide a useful model in which to study the action of this
agent. Pursuant to previous indications that the toxic ac-
tion ofTCDD may result from its interference with nor-
mal hormone action (23), a number of studies have now
reported examples of this phenomenon (24). Malignant hu-
man keratinocytes appear defective in their ability to
differentiate terminally (25). However, they can exhibit at
confluence a moderately high level of keratinocyte trans-
glutaminase, which is expressed in normal epidermis in
the upper spinous layer (7), and a high keratin content.
Hydrocortisone in the culture medium stimulates these
markers 4- to 6-fold in the SCC-13 cell line. TCDD has lit-
tle effect on their expression in the absence of added
glucocorticoid, but it largely antagonizes the action of
hydrocortisone when the cells are grown in the presence
of both agents (26).
In contrast to SCC-13, the SCC-4 cell line shows rela-
tively little keratinocyte character but does exhibit great
sensitivity to vitamin A in induction of tissue transgluta-
minase to high levels (11). TCDD in the medium prevents
the induction by retinoic acid or retinyl acetate. The con-
centration dependence of this action (EC50 = 20 pM) was
virtually identical to that for induction of aryl hydro-
carbon hydroxylase, compatible with mediation by the Ah
receptor. The loss of cell sensitivity to vitamin A was also
observed with 3-methylcholanthrene and benzo[a]pyrene
but not pyrene or dibenzofuran. If, as generally assumed,
the tumor promoting activity ofTCDD is receptor medi-
ated, this result suggests the promoting activity of car-
cinogenic polycyclic aromatic hydrocarbons may be at
least in part conferred in the same way, independent of
the generation of DNA-damaging electrophiles (24).
Materials and Methods
Cell Culture
SCC-12F2 keratinocytes were grown with 3T3 feeder
layer support (27) in a 3:1 mixture of Dulbecco-Vogt Ea-
gle's and Ham's F-12 media supplemented with fetal bo-
vine serum (5%), hydrocortisone (0.4 ,g/mL), transferrin
(5 ,ug/mL), insulin (5 ,ug/mL), adenine (0.18 mM), triiodo-
thyronine (20 pM), and antibiotics. The medium for the rat
epithelial cells (28,29) also contained epidermal growth
factor and cholera toxin (each approximately 10 ng/mL).
The medium was changed at 3 to 4 day intervals. In
experiments employing TPA or 3-MC (both from Sigma
Chemical Co., St. Louis, MO), the agent was dissolved in
dimethylsulfoxide and diluted from a stock solution into
medium to give a final solvent concentration of 0.1%. Cul-
tures were treated starting 1 to 2 days after inoculation
and at each medium change with the indicated agent or
solvent (control) and after approximately 2 weeks were
fixed and stained with rhodanile blue (30). Rat epithelial
cells were used for toxicity studies in passages 3 to 4 (ap-
proximately 30 to 40 generations).
Assays
SCC-12F2 cells were rinsed with isotonic saline, scraped
into tubes with buffer (10 mM Tris-Cl, pH 7.5, 1 mM
EDTA, 1% Emulgen 911) and stored frozen. Thawed sam-
ples were disrupted by sonication and centrifuged at
100,OOOg for 45 min. Ib measure involucrin content, ali-
quots of the supernatant of appropriate dilution were in-
cubated overnight with 0.06 mL of rabbit anti-involucrin
antiserum (2), diluted 1:1500, transferred to a 96-well
plate containing adsorbed, partially purified involucrin,
incubated 30 min, and washed. Antibodies remaining
bound to the wells were quantitated by treatment with
protein A-alkaline phosphatase conjugate and subsequent
incubation with p-nitrophenylphosphate. Absorbance
values at 405 nm were measured using a Tltertek Mul-
tiskan, and involucrin values were calculated from stan-
dard curves generated in parallel with samples of chro-
matographically purified involucrin (8). From the original
crude sonicates, aliquots were assayed for trans-
glutaminase in final volumes of 0.26 mL containing 0.5 mg
of dimethylcasein, 100 mM Tris-HCl (pH 8.2), 4 mM
CaCl2, 0.4 mM EDTA, 5 mM dithioerythritol, 15 mM
putrescine, and 0.5 ,Ci of 3H-putrescine. After 30 min in-
cubation at 370C, protein-bound radioactivity was reco-
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vered by trichloroacetic acid precipitation on glass fiber
filters, rinsed with trichloroacetic acid and ethanol, and
measured by scintillation counting (11). Measures of in-
volucrin and transglutaminase were normalized to protein
content of the sonicate assayed with bicinchoninic acid
(31).
For assay of estrogen receptors$ rat endometrial cells
(passages 10-15) were treated with forskolin (dissolved in
ethanol; final solvent concentration 0.05%) just as they
reached confluence. After appropriate incubation, the cul-
tures were rinsed in isotonic saline, scraped into tubes,
and sonicated in buffer (10 mM Tris-HCl, pH 7.4, 20 mM
NaMoO4, 2mM dithioerythritol). Samples were then ad-
justed to 0.4 M in KCl, stirred for 20 min at OOC, and cen-
trifuged for 45 min at 100,000g. Aliquots of the superna-
tant were adjusted to 1 nM in 3H-estradiol (tv 100
Ci/mmole; New England Nuclear, Boston, MA) ± 200 nM
unlabeled estradiol, incubated for 1 hr at 300C, and the
bound ligand recovered by hydroxyapatite precipitation
and subsequent ethanol elution (32). Several other es-
tradiol concentrations were employed in occasional experi-
ments and gave essentially the same results. Specific
binding was normalized to protein content in the soluble
extract (typically 1 mg/mL) as measured by Coomassie
G-250 dye binding (33).
Results
12-O-Tetradecanoylphorbol-13-Acetate
Cell lines derived from epidermal squamous carcinomas
are generally insensitive to the toxic effects of 12-0-tetra-
decanoylphorbol-13-acetate (TPA) compared to normal
epidermal cells (34,35), as shown for SCC-13 in Figure 1.
A special case is the human epidermal line SCC-12F2, im-
SCC-13_
SCC- 1 2F2:. ~ 1l
TA (nM) 0.01
mortal but not malignant (27), which is reduced in colony-
forming efficiency by this agent (34). As illustrated in Fig-
ure 1, TPA produces a noticeable reduction in growth at
0.16 nM and largely prevents colony expansion at 1.6 to
16 nM. At the highest concentration tested, 160 nM, the
growth rate was higher than at 1.6 to 16 nM. Close inspec-
tion through the culture microscope indicated that slow
cell growth was continuing at the latter concentrations,
but discrete colonies were not easily distinguishable by
staining, probably due at least in part to the altered mor-
phology of the cells and loss of their usual close associ-
ation with each other. At higher inoculation densities, the
treated cultures reached confluence and could be main-
tained for several weeks.
As found with other neoplastic keratinocyte lines such
as SCC-13 (36), SCC-12F2 cells showed little differen-
tiated character during log-phase growth with 3T3 feeder
layer support. However, keratinocyte properties became
evident as the cultures reached confluence, as shown in
Figure 2. Transglutaminase activity rose from very low
to appreciable values as the cells approached confluence,
reaching approximately 10-fold higher levels than during
mid-log-phase growth. Involucrin content increased
50-fold or more from basal levels, but this rise consistently
occurred several days later than that of the transglu-
taminase. The ability of the cells to make cross-linked
envelope structures upon stimulation by the ionophore
X537A increased largely in concert with measured activ-
ity of the cross-linking enzyme. At early times, however,
it was evident that the enzyme alone is insufficient to
form the structures (evidently, substrates are lacking). In-
corporation of involucrin likely stabilizes the structures,
but is not required for their initial formation under these
artificial conditions. Competence levels remained high as
the cells were maintained at confluence, indicating that
1*6 16 160
FIGURE 1. Effect of 12-0-tetradecanoylphorbol-13-acetate (TPA) on growth of SCC-12F2 and SCC-13 cells.
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FIGURE 2. Kinetics of expression of transglutaminase, involucrin, and
envelope competence in SCC-12F2 cells. Cultures inoculated with 105
cells/dish were harvested at the times indicated and assayed. Values
shown are the mean and range of determinations in duplicate cultures.
The range of envelope competence measurements, performed as previ-
ously described (36), was ±6%. The cultures became confluent on day
10 (1). In other experiments, transglutaminase activity measured
several days earlier than the first time point shown was approximately
10% of the maximum value attained shortly after confluence.
necessary components were present in sufficient amounts
despite the slow decline detected in both transglu-
taminase and involucrin. Similar observations have been
made using SCC-9 cells, in which involucrin accumulation
follows the rise in transglutaminase by at least a week
(37). Measures of ionophore-stimulated envelope-forming
ability evidently reflect a property of the cells for which
a correspondence to certain transglutaminase substrates
is not yet established, and which may even vary with the
physiological state of the cells (38,39). Thus, the present
work has concentrated specifically on expression of the
known markers transglutaminase and involucrin.
Cultures treated chronically with TPA were examined
for their expression of these keratinocyte differentiation
markers, as shown in Figure 3. The cells were harvested
5 to 6 days after confluence, when the markers in paral-
lel control cultures were at maximal values. Measure-
ments made 2 to 3 weeks after confluence gave similar
results, although the control values were considerably
lower, as indicated in Figure 2. Cultures treated with
1 nM TPA showed a small elevation in the specific activ-
ity of both markers, while those treated with higher con-
centrations showed substantial reductions. The involucrin
content, more sensitive than transglutaminase activity,
was reduced to less than 10% of the control value at 1 AM
TPA.
Polycyclic Aromatic Hydrocarbon ¶bxicity
Epithelial cells from a variety of rat tissues are cultiv-
able with 3T3 feeder layer support (28,29). A survey of
their sensitivities to inhibition of growth by 3-methyl-
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FIGURE 3. Effect of TPA on transglutaminase and involucrin expression
in SCC-12F2 cells. Cultures grown as in Fig. 2 were treated with the
indicated concentration of TPA and harvested 3 days after confluence
for assay of transglutaminase (0) and involucrin (0).
cholanthrene (3-MC) has shown striking differences, as
summarized in Table 1. This agent produced its most
powerful effect in rat epidermal and mammary epithelial
cells, with a concentration dependence similar to that ob-
served previously for epidermal cells (40), whereas blad-
der, prostate, thyroid, and endometrial cells, for example,
were insensitive. The basis for this difference in response
remains to be elucidated. That the sensitive cells
responded only to a small extent to TCDD compared to
3-MC in the medium, as shown in Figure 4, indicates that
the production of metabolites was important and not sim-
ply activation of whatever genes are under the control of
the Ah receptor.
The action of neither TCDD nor 3-MC on the epidermal
cells was altered by omission of epidermal growth factor
from the medium (S. E. Crane and R. H. Rice, unpub-
lished), indicating that inhibition of growth could not be
ascribed primarily to the loss of receptors for this poly-
peptide that occurs in human epidermal and certain kera-
tinocyte lines (41,42). Although rat epidermal cells are
highly sensitive to 3-MC in early passage, we have previ-
ously found that upon continued propagation both sensi-
tivity and expression of aryl hydrocarbon hydroxylase ac-
tivity are lost, suggesting the latter is necessary for the
evident toxicity. However, similar to previous findings, the
capacities to metabolize polycyclic aromatic hydrocarbons
were comparable in the cell types examined (epidermal,
esophageal, forestomach, vaginal, mammary). Such meas-
urements in growing or confluent cultures have not dis-
tinguished sensitive and insensitive cell types, implicat-
242
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FIGURE 4. Sensitivity of rat mammary epithelial cells
ing other factors as well in determining the response (40,
S. E. Crane and R. H. Rice, unpublished data). The actual
metabolites have not been analyzed, leaving open the pos-
sibility of critical differences in hydroxylation, conjuga-
tion, DNA repair, quinone or radical scavenging, or even
cooxidation with arachidonic acid upon membrane dam-
age. In regard to the latter possibility, growth of the rat
mammary cells in the presence of cyclooxygenase or lipo-
xygenase inhibitors indomethacin or BW755C (up to 3 JAM
or 1 MM, respectively, above which the agents were toxic
alone) did not reduce the toxicity of 0.2 to 2 MM
benzo[a]pyrene in the growth medium. Moreover, addi-
tion of 1 MM arachidonic acid to the medium did not inhibit
the cell growth alone or in the presence of benzo[a]pyrene
(E. Choi and R. H. Rice, unpublished).
Estrogen Receptor Modulation
Rat endometrial cells grown with feeder layer support
express estrogen receptors at a modest level (32), a sta-
ble characteristic even after approximately 200 genera-
tions. Additives to the culture medium such as hydro-
Table 1. Inhibition of colony expansion.
Inhibitory activitya
Epithelial origin TCDD 3-MC
Epidermal + +++
Mammary + +++
Seminal vesicle + + +
Forestomach + + +
Pituitary + +
Esophageal - -
Vaginal
Prostate - -
Thryoid - -
Bladder b
Endometrial b
'The degree of colony growth inhibition in the presence of TCDD
(10 mM) or 3-MC (4 pM) was judged in comparison with parallel solvent-
treated controls as none (-) or mild (+) to severe (+ +).bNot tested.
tDDgrowth .... by ... 3nMaM C (2 MM).
,to growth inhibition by TCDD (10 nM) and 3-MG (2 ,uM).
cortisone and epidermal growth factor had little or no
observable effect on receptor content. However, agents in-
creasing production of cAMP (cholera toxin, forskolin)
were found to raise substantially the receptor level with-
out significant effect on affinity for the ligand. As shown
in Figure 5, forskolin at high concentration (100 MM) in-
creased the receptor level by 3- to 6-fold with an EC50 of
approximately 3 MM (left panel). Forskolin has also been
reported to increase glucocorticoid receptor levels 2-fold
in murine lymphoma cells without altering affinity for the
ligand (43). Steroid receptors are known to be subject to
phosphorylation, which modulates their ability to bind
ligand and may alter their affmity for DNA acceptor sites
(44). The estrogen receptor is a substrate for a calmodulin-
dependent kinase that phosphorylates a critical tyrosine
residue (45). The present findings indicate forskolin addi-
tion does not increase receptor number simply by
stimulating cAMP-dependent receptor phosphorylation.
Its action takes approximately 6 hr for maximal effect
(Figure 5, right panel) and is prevented by cycloheximide,
indicative of a requirement for protein synthesis (32).
Physiological agents raising intracellular cAMP, includ-
ing follicle-stimulating hormone and prostaglandins E 1 or
E2, are known to be effective in modulating functions of
estrogen responsive cells of the female genital tract (46).
In a search for endogenous effectors that might be of
physiological relevance, cultures were treated with crude
preparations of several peptide hormones obtained from
the National Hormone and Pituitary Program. Standard
preparations of ovine (follicle stimulating hormone), por-
cine (follicle stimulating hormone, leutinizing hormone),
and rat (growth hormone, prolactin, hypothalamic extract)
origin employed under various conditions did not materi-
ally alter the receptor level. In some experiments, treat-
ment of the cultures with prostaglandins E1 or E2 led to
a 2- to 3-fold increase in receptor level over a 4 to 6 hr time
period (prostaglandins B1, '2 and F2Z were virtually inac-
tive), but this finding was not readily reproducible, per-
haps due to variable endogenous prostaglandin produc-
tion by the epithelial or the few remaining 3T3 cells.
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FIGURE 5. Estrogen receptor stimulation by forskolin. Rat endometrial cells were treated with forskolin at the indicated concentrations for 18 hr
(left panel) or at 100 ,pM for the indicated times (right panel). The cultures were then harvested and assayed for receptor content.
Discussion
Treatment of cultured keratinocytes from normal mouse
or human epidermis with TPA induces a state resembling
terminal differentiation in a majority of the cells, although
a substantial fraction of transiently resistant cells is evi-
dent corresponding to the germinative population
(34,35,41). This finding has suggested that sensitivity to
TPA requires some differentiated function lacking in basal
cells and certain human squamous carcinoma lines. How-
ever, such carcinoma cells can express considerable
differentiated function upon reaching confluence (36), sug-
gesting they might show a sensitivity to TPA under op-
timal circumstances. Growth of the malignant cell line
SCC-9 with 1 nM to 1 IAM TPA in the medium gave no hint
of toxicity or stimulation of differentiation. Nevertheless,
expression of involucrin and particulate transglutaminase
in confluent cultures was greatly suppressed (37). In the
present experiments, it is clear that the latter phenome-
non occurs in SCC-12F2, a premalignant line in which
TPA does inhibit cell growth. Whether a transient stimu-
lation of expression of the two markers occurs after ini-
tial TPA treatment has not yet been established.
Upon chronic treatment of SCC-12F2 (and SCC-9) cul-
tures, the TPA concentration dependence shows that
involucrin is considerably more sensitive to suppression
than transglutaminase. Whether this phenomenon repre-
sents an effect on transcription remains to be seen. The
keratinocyte transglutaminase is subject to phosphory-
lation, which is stimulable 5-fold by treatment of cul-
tured normal epidermal cells for several hours with TPA
(R. Chakravarty and R. H. Rice, unpublished). Thus, post-
translational modification(s) could account for some alter-
ation in measured activity. Moreover, involucrin is quite
sensitive to proteolytic degradation and could be subject
to rapid depletion as a consequence of protease activation.
Indeed, protein kinase C is dramatically depleted in a va-
riety of cell types, including A431 malignant human ker-
atinocytes (48), as well as in mouse skin (49), perhaps due
to enhanced proteolysis (50). The possibility that TPA-
mediated production of reactive oxygen species (51,52)
may contribute to this differentiation suppression has not
been ruled out, however. If protein kinase C ordinarily
mediates keratinocyte differentiation, suggested by its ob-
served stimulation of differentiated properties in cultured
normal keratinocytes, then its depletion could be respon-
sible for the suppressive effect in these chronically
treated cells. Regardless of this hypothesis, a biphasic
growth inhibition response induced by TPA as in
SCC-12F2 has been reported in a number of cell types
(53). In some cases (such as this), perhaps a drastic deple-
tion of protein kinase C at the highest concentrations of
TPA employed could release the cells from a growth in-
hibitory influence of the kinase activity present at lower
concentrations.
Although keratinocytes from various anatomic sites
have much in common, they retain and under appropri-
ate circumstances display intrinsic differences in their
differentiation program (54), perhaps arising in part as a
consequence of their developmental pathways. In addition
to pharmacokinetic factors, these differences are likely to
result in distinctive responses to physiological and patho-
logical conditions. The striking contrast in the response
of cultured rat epithelial cells to the polycyclic aromatic
hydrocarbon 3-MC suggests these intrinsic differences
could have major influences on carcinogen target speci-
ficity, for example. It is not clear at present how relative
toxicity (growth inhibition) may relate to carcinogenicity
in this instance. One possibility, similar to the selection
scheme proposed for preneoplastic lesions of the rat liver
(55), is that epidermal cells metabolizing the agent are
prevented from growing. Those variants arising which
lack such metabolic capability may then be selectively
provided with the opportunity to replace the normal cells.
Variants lacking aryl hydrocarbon hydroxylase that are
not sensitive to 3-MC toxicity do arise in epidermal cell
populations even without 3-MC treatment upon continued
passage (28). Alternately, one could imagine that con-
tinued carcinogen metabolism by the esophageal cells
without toxicity might permit a greater burden of DNA
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damage to accumulate, thereby enhancing the rate of
progression to malignancy. Further infornation on the de-
gree of DNA damage suffered by these cells and the ef-
fect of treatment on their growth properties may help
choose among such possible scenarios. Insensitivity to
3-MC and B[a]P but not to dimethylbenzanthracene, a
more potent carcinogen at this target site in vivo, has
been noted previously in primary cultures of rat tracheal
epithelial cells (56). These cells express in surface culture
the metabolic capabilities observed in organ culture (5?).
While rodent epidermis and mammary epithelium are
well-known target sites for polycyclic aromatic hydro-
carbon carcinogenesis, few studies have examined syste-
matically the relative target sensitivity of these and other
sites. If the observed sensitivity in culture reflects that
in the animal, examination of its biochemical basis may be
of utility in improving extrapolation among epithelia and
perhaps species.
'Ib what degree differentiated properties of the cultured
rat cells correspond to the epithelia of origin remains to
be explored in detail. Those derived from stratified squa-
mous epithelia presumably retain the most normal func-
tion, although probably resembling the hyperproliferative
state observed in human epidermal cells (58). With re-
spect to other cell types, the adoption of features such as
high keratin content and envelope-forming ability (29) and
expression of a particulate transglutaminase (14) indicate
a reprogramming resembling, but not necessarily identi-
cal to (59), squamous metaplasia. In any case, the culture
phenotype appears to approximate behavior within the
cellular repertoire in vivo under conditions of stress (hor-
monal imbalance, vitamin deprivation, physical trauma,
neoplastic influence). Squamous metaplasia is inducible
even in the rodent mammary epithelium (60) and is seen
in human mammary tissue (61). New biochemical proper-
ties may well influence the target susceptibility of these
cells to exogenous agents or alter the ensuing pathology.
Loss of characteristic specialized function may be only
partial, with enough remaining to permit study of impor-
tant normal processes. Thus, the responsiveness of estro-
gen receptor content in the rat endometrial cells to agents
elevating intracellular cAMP suggests possible usefulness
in studying the mechanism of this phenomenon and con-
sequences of its disturbance. Enhanced estrogen respon-
siveness of the cells by cAMP elevation may merit explo-
ration, especially in conjunction with alterations in the
growth substratum that have permitted maintenance of
normal function in cultured mammary and tracheal
epithelial cells (62,63). In addition, since the adenyl cy-
clase/phosphodiesterase pathway is sensitive to perturba-
tion by exogenous agents, the cells may provide a suitable
model for examining certain types of reproductive tox-
icity.
As these results demonstrate, epithelial cell culture
models can be instrumental in elucidating physiological
and biochemical bases for differences in regulation and re-
sponse among tissue types and species. Further investi-
gations in these directions, in conjunction with in vivo ob-
servations, could ultimately aid in prediction of human
responses to new or uncharacterized toxic substances.
We thank Dr. P. R. Cline for assistance in treating SCC-12F2 cultures
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